17 March 2024 - Zymfentra is commercially available across the US on 15 March 2024. ...
8 January 2024 - AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement ...
5 December 2023 - Express Scripts to add Zepbound to National Preferred Formulary. ...
14 November 2023 - Bayer today announced that, following discussions with the US FDA, it will work with the FDA on ...
31 October 2023 - Today, US Department of Health and Human Services Secretary Xavier Becerra released the following statement regarding ...
2 October 2023 - Adalimumab-adbm will be priced at an 81% discount to Humira (adalimumab). ...
20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...
12 September 2023 - Ferring launches ABLE-41 Real World Evidence Study, a patient registry to explore early use, experiences and outcomes ...
30 August 2023 - Narcan nasal spray will be the first, life-saving emergency medicine for opioid overdose available on shelves beginning ...
5 August 2023 - Several barriers to access to preexposure prophylaxis for HIV could be alleviated by making it available over ...
13 July 2023 - Distribution through Mark Cuban Cost Plus Drug Company introduces affordably priced SGLT2 inhibitors. ...
11 July 2023 - Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars ...
3 July 2023 - CMS grants Fresenius Kabi permanent, product-specific Q Code for Idacio (adalimumab-aacf). ...
3 July 2023 - Biocon Biologics today announced that Hulio (adalimumab-fkjp) injection, a biosimilar to Humira (adalimumab), is now available ...
1 July 2023 - After quite the regulatory process, with Roctavian (valoctocogene roxaparvovec) BioMarin has a potential blockbuster. On 29 ...